IN BRIEF: EDX Medical inks 3-year services deal with Royal Marsden

EDX Medical Group PLC - Cambridge, England-based firm that develops digital diagnostic products ...

Alliance News 10 March, 2025 | 7:02AM
Email Form Facebook Twitter LinkedIn RSS

EDX Medical Group PLC - Cambridge, England-based firm that develops digital diagnostic products and services to treat cancer, heart disease, and infectious diseases - Signs master services agreement with Royal Marsden NHS Foundation Trust. The agreement will see EDX supply services to Royal Marsden over a three-year period. EDX Medical Founder & Chief Scientific Officer Chris Evans comments: "I am delighted EDX Medical has now been appointed as a supplier of diagnostic solutions and services to help serve the needs of one of the world's most eminent cancer hospitals."

Current stock price: 12.75 pence

12-month change: up 24%

By Christopher Ward, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
EDX Medical Group PLC Ordinary Shares 12.75 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures